MIRA INFORM REPORT

Report No. :	504221
Report Date :	20.04.2018

IDENTIFICATION DETAILS

Name :	CUTERA, INC.
Registered Office :	Corporation Trust Center 1209 Orange St, Wilmington, New Castle, De
Country :	United States
Financials (as on) :	2016
Date of Incorporation :	10.08.1998
Legal Form :	Corporation
Line of Business :	· Manufacturing of Electromedical and Electrotherapeutic Apparatus · Subject is a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide.
No. of Employees :	230

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23^rd January 2017)

MIRA’s Rating :

A

Credit Rating	Explanation	Rating Comments
A	Acceptable Risk	Business dealings permissible with moderate risk of default

Status :	Good
Payment Behaviour :	Regular
Litigation :	Clear

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

ECGC Country Risk Classification List

Country Name	Previous Rating (30.09.2017)	Current Rating (31.12.2017)
United States	A1	A1

Risk Category	ECGC Classification
Insignificant	A1
Low Risk	A2
Moderately Low Risk	B1
Moderate Risk	B2
Moderately High Risk	C1
High Risk	C2
Very High Risk	D

UNITED STATES - ECONOMIC OVERVIEW

The US has the most technologically powerful economy in the world, with a per capita GDP of $59,500. US firms are at or near the forefront in technological advances, especially in computers, pharmaceuticals, and medical, aerospace, and military equipment; however, their advantage has narrowed since the end of World War II. Based on a comparison of GDP measured at purchasing power parity conversion rates, the US economy in 2014, having stood as the largest in the world for more than a century, slipped into second place behind China, which has more than tripled the US growth rate for each year of the past four decades.

In the US, private individuals and business firms make most of the decisions, and the federal and state governments buy needed goods and services predominantly in the private marketplace. US business firms enjoy greater flexibility than their counterparts in Western Europe and Japan in decisions to expand capital plant, to lay off surplus workers, and to develop new products. At the same time, businesses face higher barriers to enter their rivals' home markets than foreign firms face entering US markets.

Long-term problems for the US include stagnation of wages for lower-income families, inadequate investment in deteriorating infrastructure, rapidly rising medical and pension costs of an aging population, energy shortages, and sizable current account and budget deficits.

The onrush of technology has been a driving factor in the gradual development of a "two-tier" labor market in which those at the bottom lack the education and the professional/technical skills of those at the top and, more and more, fail to get comparable pay raises, health insurance coverage, and other benefits. But the globalization of trade, and especially the rise of low-wage producers such as China, has put additional downward pressure on wages and upward pressure on the return to capital. Since 1975, practically all the gains in household income have gone to the top 20% of households. Since 1996, dividends and capital gains have grown faster than wages or any other category of after-tax income.

Imported oil accounts for more than 50% of US consumption and oil has a major impact on the overall health of the economy. Crude oil prices doubled between 2001 and 2006, the year home prices peaked; higher gasoline prices ate into consumers' budgets and many individuals fell behind in their mortgage payments. Oil prices climbed another 50% between 2006 and 2008, and bank foreclosures more than doubled in the same period. Besides dampening the housing market, soaring oil prices caused a drop in the value of the dollar and a deterioration in the US merchandise trade deficit, which peaked at $840 billion in 2008. Because the US economy is energy-intensive, falling oil prices since 2013 have alleviated many of the problems the earlier increases had created.

The sub-prime mortgage crisis, falling home prices, investment bank failures, tight credit, and the global economic downturn pushed the US into a recession by mid-2008. GDP contracted until the third quarter of 2009, the deepest and longest downturn since the Great Depression. To help stabilize financial markets, the US Congress established a $700 billion Troubled Asset Relief Program (TARP) in October 2008. The government used some of these funds to purchase equity in US banks and industrial corporations, much of which had been returned to the government by early 2011. In January 2009, Congress passed and former President Barack OBAMA signed a bill providing an additional $787 billion fiscal stimulus to be used over 10 years - two-thirds on additional spending and one-third on tax cuts - to create jobs and to help the economy recover. In 2010 and 2011, the federal budget deficit reached nearly 9% of GDP. In 2012, the Federal Government reduced the growth of spending and the deficit shrank to 7.6% of GDP. US revenues from taxes and other sources are lower, as a percentage of GDP, than those of most other countries.

Wars in Iraq and Afghanistan required major shifts in national resources from civilian to military purposes and contributed to the growth of the budget deficit and public debt. Through FY 2018, the direct costs of the wars will have totaled more than $1.9 trillion, according to US Government figures.

In March 2010, former President OBAMA signed into law the Patient Protection and Affordable Care Act (ACA), a health insurance reform that was designed to extend coverage to an additional 32 million Americans by 2016, through private health insurance for the general population and Medicaid for the impoverished. Total spending on healthcare - public plus private - rose from 9.0% of GDP in 1980 to 17.9% in 2010.

In July 2010, the former president signed the DODD-FRANK Wall Street Reform and Consumer Protection Act, a law designed to promote financial stability by protecting consumers from financial abuses, ending taxpayer bailouts of financial firms, dealing with troubled banks that are "too big to fail," and improving accountability and transparency in the financial system - in particular, by requiring certain financial derivatives to be traded in markets that are subject to government regulation and oversight.

In December 2012, the Federal Reserve Board (Fed) announced plans to purchase $85 billion per month of mortgage-backed and Treasury securities in an effort to hold down long-term interest rates, and to keep short-term rates near zero until unemployment dropped below 6.5% or inflation rose above 2.5%. The Fed ended its purchases during the summer of 2014, after the unemployment rate dropped to 6.2%, inflation stood at 1.7%, and public debt fell below 74% of GDP. In December 2015, the Fed raised its target for the benchmark federal funds rate by 0.25%, the first increase since the recession began. With continued low growth, the Fed opted to raise rates several times since then, and in December 2017, the target rate stood at 1.5%.

In December 2017, Congress passed and President Donald TRUMP signed the Tax Cuts and Jobs Act, which, among its various provisions, reduces the corporate tax rate from 35% to 21%; lowers the individual tax rate for those with the highest incomes from 39.6% to 37%, and by lesser percentages for those at lower income levels; changes many deductions and credits used to calculate taxable income; and eliminates in 2019 the penalty imposed on taxpayers who do not obtain the minimum amount of health insurance required under the ACA. The new taxes took effect on 1 January 2018; the tax cut for corporations are permanent, but those for individuals are scheduled to expire after 2025. The Joint Committee on Taxation (JCT) under the Congressional Budget Office estimates that the new law will reduce tax revenues and increase the federal deficit by about $1.45 trillion over the 2018-2027 period. This amount would decline if economic growth were to exceed the JCT’s estimate.

Source : CIA

STATUTORY INFORMATION
Legal Name:	CUTERA, INC.
Trade Name:	CUTERA
ID:	2930201
Date Created:	1998
Date Incorporated:	8/10/1998
Legal Address:	CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, New Castle, DE
Operative Address:	3240 Bayshore Boulevard, Brisbane, CA 94005 United States
Telephone:	415 657 5576
Fax:	415 330 2442
Legal Form:	Corporation
Email:	NA
Registered in:	DELAWARE, USA
Website:	www.cutera.com
Contact:	James A Reinstein, President & Chief Executive Officer
Staff:	230 Employees
Activity:	SIC Code: 3845, Electromedical and Electrotherapeutic Apparatus NAICS Code: 334510, Electromedical and Electrotherapeutic Apparatus Manufacturing
BANKS The company does not make its banking data public
HISTORY Cutera, Inc. was founded in 1998 and is headquartered in Brisbane, California.
Key Developments:	Cutera, Inc. announced delayed annual 10-K filing Mar 16 18 On 03/16/2018, Cutera, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC. Cutera, Inc. Presents at 30th Annual ROTH Conference, Mar-12-2018 12:00 PM Feb 22 18 Cutera, Inc. Presents at 30th Annual ROTH Conference, Mar-12-2018 12:00 PM. Venue: The Ritz Carlton, Laguna Niguel in Orange County, 1 Ritz Carlton Dr., Dana Point, California, United States. Speakers: James A. Reinstein, CEO, President & Director, Sandra A. Gardiner, Executive VP & CFO. Cutera, Inc. Presents at 2018 American Academy of Dermatology (AAD) Annual Meeting, Feb-16-2018 Feb 15 18 Cutera, Inc. Presents at 2018 American Academy of Dermatology (AAD) Annual Meeting, Feb-16-2018 . Venue: San Diego Convention Center, San Diego, California, United States.
PRINCIPAL ACTIVITY
Cutera, Inc., is a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide.
Products/Services description:	The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating. It also provides excel V, a vascular and benign pigmented lesion treatment platform; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin rejuvenation by treating discoloration, fine lines, and laxity. In addition, the company offers GenesisPlus system, a laser product for use in the temporary increase of clear nails in patients with onychomycosis, as well as for the treatment of fine wrinkles, diffuse redness, and rosacea; solera console platform, including Opus and Titan consoles; and CoolGlide systems, as well as provides myQ, a third-party sourced system for the Japanese market. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; skin care products; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills and marketing brochures through the Internet.
Brands:	No brands registered
Sales are:	Wholesale
Clients:	The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, physicians performing aesthetic treatments in non-medical offices, and other qualified practitioners, as well as for physicians offering aesthetic treatments in non-medical offices. Art Tecnica SA De Cv
Suppliers:	NA
Operations area:	National and International
The company imports from	No import
The company exports to	Mexico
The subject employs	230 Employees
Payments:	Regular
LOCATION
Headquarters :	CUTERA World Headquarters 3240 Bayshore Boulevard Brisbane, CA 94005
Comments:	NA
Branches:	Cutera, Inc. does not have branches
Main Competitors	NA
Related Companies:	CUTERA Japan CUTERA K.K. 12-10 Sakuragaoka-cho Shibuya Infosys Annex Bldg. 3F Shibuya-ku, Tokio, Japan 150-0031 P: +81-3-5456-6325 F: +81-3-5456-2213 CUTERA France 1 rue Georges Charpak Bât C LIEUSAINT FRANCE 77127 P: +33 1 60 62 24 40 F: +33 1 60 34 31 75 CUTERA Benelux CUTERA SPRL Boulevard Auguste Reyers 80 B-1030 Bruselas Bélgica P: +32 468 20 78 87 CUTERA Switzerland GmbH CUTERA Switzerland GmbH Zollikerstrasse 27 CH-8032 Zurich Suiza P: +41 (0)79 173 68 05 P: +41 79 829 7627 (French, Italian) P: +41 79 590 7803 (German)
GROUP STRUCTURE AND SUBSIDIARY COMPANIES
Listed at the stock exchange:	NO
Capital:	NA
Shareholders:	This is a private company. We could not confirm major holders.
Management:	James A Reinstein, President & Chief Executive Officer Larry E. Laber, Executive Vice President of Sales - North America Ronald J. Santilli, Executive Officer
FINANCIAL INFORMATION
The company does not make its financial statements public. The following information has been provided by private sources:
USD 2016
Revenue	118 060 000
Cash flow	Normal
LEGAL FILINGS
Patents	Split pulse picosecond laser for tattoo removal Patent number: 9913688 Abstract: A method of removing tattoos or pigmented lesions by generating at least two laser pulses having a pulse width in the picosecond range, where the peak power of each pulse is less than 15 GW/cm2 and where the spacing between the pulses is less than ten nanoseconds, and directing the pulses to the tattoo or pigmented lesion to be removed. Type: Grant Filed: September 24, 2014 Date of Patent: March 13, 2018 Assignee: Cutera, Inc. Inventor: Michael Karavitis System and method for dermatological lesion treatment using gas discharge lamp with controllable current density Patent number: 8920409 Abstract: A device for treatment of dermatological lesions includes a gas discharge lamp for generating a plurality of different electromagnetic radiation treatments. A power supply for driving the gas discharge lamp is selectively controlled to drive the gas discharge lamp to output a first electromagnetic treatment when an area of skin being treated has a pigmented lesion, and to drive the gas discharge lamp to output a second electromagnetic treatment when the area of skin being treated has a vascular lesion, where the second electromagnetic treatment has a spectral distribution that is blue-shifted relative to the spectral distribution of the first electromagnetic treatment. Type: Grant Filed: October 1, 2008 Date of Patent: December 30, 2014 Assignee: Cutera, Inc. Inventors: Scott A. Davenport, David A. Gollnick Method for treatment of post-partum abdominal skin redundancy or laxity Patent number: 8915906 Abstract: A system and method for providing treatments of electromagnetic radiation to areas of post-partum abdominal skin. The treatments provide for raising the temperature in a portion of post-partum abdominal skin to a treatment temperature, which is sufficient to reduce the laxity or redundancy of the post-partum skin. In one embodiment the treatment can provide treatment exposures to sub-areas, of an area of post-partum abdominal skin which has been identified for treatment, and bring a temperature of the tissue being treated to at 50° C. Type: Grant Filed: August 8, 2005 Date of Patent: December 23, 2014 Assignee: Cutera, Inc. Inventors: Scott A. Davenport, David A. Gollnick, Michael Levernier, Gregory J. R. Spooner Method for heating skin using light to provide tissue treatment Patent number: 8870856 Abstract: A system and method for using a light source to treat tissue with NIR light. The operation provides for generating higher temperatures in deeper layers of tissue relative to higher layers of tissue. The increased temperature in dermal layers can operate to induce collagen shrinkage, or remodeling. One of the light sources for providing a broad spectrum of NIR light is a filament light. The light from the filament lamp can be selectively filtered, and after filtering this light is applied to the skin, where the selective filtering can enhance the ability to elevate the temperature of deeper layers of tissue, relative to layers of tissue which are closer to the surface of the skin. Type: Grant Filed: February 27, 2004 Date of Patent: October 28, 2014 Assignee: Cutera, Inc. Inventors: Kevin P. Connors, David A. Gollnick, Dean A. MacFarland, Greg Spooner Aesthetic treatment for wrinkle reduction and rejuvenation Patent number: 8656931 Abstract: A dermatological treatment method includes directing laser energy having a wavelength of 2.79 ?m onto skin. According to disclosed methods, the energy can function to ablate a first portion of epidermal tissue, coagulate an underlying second portion of epidermal tissue, and promote collagen formation in tissue of the underlying dermis. In an exemplary treatment apparatus, a laser using a YSGG gain medium is mounted in a handpiece. The handpiece may include a two-axis scanner to allow for uniform scanning of the energy over the tissue surface. Type: Grant Filed: September 6, 2012 Date of Patent: February 25, 2014 Assignee: Cutera, Inc. Inventors: Scott A. Davenport, David A. Gollnick, Steven Christensen, Dean A. MacFarland, Robert Bernhard Estrada BROAD-AREA IRRADIATION OF SMALL NEAR-FIELD TARGETS USING ULTRASOUND Publication number: 20140046224 Abstract: An ultrasonic transducer system for treating a portion of tissue. The ultrasonic transducer system includes a frequency generator, an ultrasonic transducer, and a transmitter element. The transducer receives an AC voltage from the frequency generator and produces an ultrasonic energy pulse at an ultrasonic frequency for a pulse width. The transmitter element is coupled to the transducer and is for irradiating a portion of skin tissue. The transmitter element has a chilled surface in contact with the skin tissue and an acoustic aperture for producing a substantially collimated energy beam. The beam has a width greater than 4 mm. Type: Application Filed: October 15, 2013 Publication date: February 13, 2014 Applicant: Cutera, Inc. Inventors: Lukas HUNZIKER, Justin MAY, Tonee SMITH Broad-area irradiation of small near-field targets using ultrasound Patent number: 8585618 Abstract: An ultrasonic transducer system for treating a portion of tissue. The ultrasonic transducer system includes a frequency generator, an ultrasonic transducer, and a transmitter element. The transducer receives an AC voltage from the frequency generator and produces an ultrasonic energy pulse at an ultrasonic frequency for a pulse width. The transmitter element is coupled to the transducer and is for irradiating a portion of skin tissue. The transmitter element has a chilled surface in contact with the skin tissue and an acoustic aperture for producing a substantially collimated energy beam. The beam has a width greater than 4 mm. Type: Grant Filed: December 18, 2009 Date of Patent: November 19, 2013 Assignee: Cutera, Inc. Inventors: Lukas Hunziker, Justin May, Tonee Smith Treatment apparatus with frequency controlled treatment depth Patent number: 8562599 Abstract: An electro-surgical system actively maintains an optimal heating profile at the electrode-patient contact surface under varying load resistivity, thereby reducing the risk of burns and maximizing patient comfort. A set of temperature sensors is integrated within the electrode assembly of the electrosurgical system. The sensors are located both at the center and the edges of the electrode. The sensors are thermally coupled to the electrode-patient contact surface. As RF power is applied, a control loop monitors the temperature at the center and edges of the electrode. If the edge temperature of the electrode is high compared to its center temperature, then the control loop increases the operating frequency, effectively driving heat towards the center of the electrode. Conversely, if the edge temperature of the electrode is low compared to its center temperature, then the control loop decreases the operating frequency, effectively driving heat towards the edges of the electrode. Type: Grant Filed: May 25, 2012 Date of Patent: October 22, 2013 Assignee: Cutera, Inc. Inventor: Greg Leyh SYSTEMS AND METHODS FOR THERMOLIPOLYSIS USING RF ENERGY Publication number: 20130245727 Abstract: Disclosed herein are systems and methods for preferentially heating subcutaneous tissue. Systems for heating subcutaneous tissue may comprise one or more radio-frequency (RF) electrodes having contoured tissue contacting surfaces, such as electrodes with concave or convex surface contours. Methods may comprise applying RF voltage or current from one or both of the handpieces to attain a target tissue and/or electrode temperature and to maintain the tissue and/or electrode at that temperature. Type: Application Filed: March 13, 2013 Publication date: September 19, 2013 Applicant: CUTERA, INC. Inventors: Amogh KOTHARE, Leonard C. DEBENEDICTIS, Dragan NEBRIGIC Methods and devices for non-ablative laser treatment of dermatologic conditions Patent number: 8474463 Abstract: The invention comprises a system and method for non-ablative laser treatment of dermatologic conditions. A laser energy is transmitted to an underlying target element in the skin. The target element is heated to a temperature of at least forty degrees Celsius. In some embodiments, a pulsed, near infrared, high peak power laser energy is used. The systems and methods of the present invention may be used to treat acne, smooth wrinkles, remove hair, treat leg veins, treat facial veins, improve skin texture, decrease pore sizes, reduce rosacea, reduce “blush/diffuse redness, reduce striae, reduce scarring, or the like. Type: Grant Filed: March 16, 2010 Date of Patent: July 2, 2013 Assignee: Cutera, Inc. Inventors: Michael Levernier, Greg Spooner, David A. Gollnick, Dean A. MacFarland Localized flashlamp skin treatments Patent number: 8460280 Abstract: A flashlamp device having a small diameter waveguide is disclosed for use in localized dermatological applications. A preferred waveguide has a curvilinear wall surface. The waveguide is supported by a plurality of spaced apart thermally-conductive elements in contact with the curvilinear wall surface allowing sufficient cooling of the waveguide while minimizing the amount of high angle light stripped from the waveguide at points of contact with the contact elements. Type: Grant Filed: April 28, 2006 Date of Patent: June 11, 2013 Assignee: Cutera, Inc. Inventors: Scott A. Davenport, Gregory J. R. Spooner, David A. Gollnick, Steven Christensen Subcutaneous electric field distribution system and methods Patent number: 8454591 Abstract: Apparatus and methods for dynamically controlling electric field distribution within tissue disposed at various depths beneath the skin at a target region of a patient's body by independently controlling the electric potential of each of a plurality of electrodes in relation to the electric potential of a ground pad. By controlling electric field distribution during a procedure, a target tissue at particular depths beneath the skin can be selectively heated relative to adjacent non-target tissue. At least one of the electrodes and the ground pad may comprise a spiral inductor comprising a substantially planar spiral of electrically conductive material. Type: Grant Filed: April 6, 2012 Date of Patent: June 4, 2013 Assignee: Cutera, Inc. Inventors: Greg Leyh, Jerzy Orkiszewski Fractional scanner for dermatological treatments Patent number: 8439901 Abstract: A dermatological treatment device is disclosed for generating a matrix of two dimensional treatment spots on the tissue. A handpiece carries a laser which generates a beam of laser pulses. The pulses are focused onto the tissue with a lens system. A diffractive element is positioned between the laser and the lens system for splitting the laser beam into a plurality of sub-beams. A scanner translates the beam over the diffractive element to generate the two dimensional spot pattern. The laser has a semi-monolithic resonator design with one integral end minor defining the output coupler and a second, independent mirror for adjustment. Type: Grant Filed: October 23, 2012 Date of Patent: May 14, 2013 Assignee: Cutera, Inc. Inventors: Scott A. Davenport, David A. Gollnick
Trademarks:	TRUSCULPT Medical device, namely, a radio frequency device for the treatment of cellulite and fat Owned by: CUTERA, INC. Serial Number: 77662751 SOLERA platform for holding hand pieces for the controlled delivery of light and energy for dermatological applications Owned by: Cutera, Inc. Serial Number: 78423121 XEO Medical lasers Owned by: Cutera, Inc. Serial Number: 78577633 TITAN hand-held medical device for the controlled delivery of light and energy for dermatological applications Owned by: Cutera, Inc. Serial Number: 78577639 SOLERA TITAN Medical system, namely, a hand-held medical device and a platform for holding the device for the controlled delivery of… Owned by: Cutera, Inc. Serial Number: 78609768 PROWAVE 770 Medical hand piece for the controlled delivery of light and energy for dermatological applications and hair removal Owned by: Cutera, Inc. Serial Number: 78633545 ACUTIP 500 Medical device hand piece for the controlled delivery of light and energy for dermatological applications Owned by: Cutera, Inc. Serial Number: 78670925 LIMELIGHT Medical devices, namely, handheld flash lamps for use in the field of dermatology Owned by: Cutera, Inc. Serial Number: 78914325 MYQ Lasers for medical use Owned by: Cutera, Inc. Serial Number: 85439037 ENLIGHTEN Lasers for the medical and cosmetic removal of tattoos and benign pigmented lesions Owned by: Cutera, Inc. Serial Number: 86216657 EXCEL HR Lasers for the medical and cosmetic removal of hair Owned by: Cutera, Inc. Serial Number: 86216663 VANTAGE Laser and light based medical devices for the medical and aesthetic treatment of face and skin Owned by: Cutera, Inc. Serial Number: 87107536 EXCEL V Laser and light based medical devices for the medical and aesthetic treatment of face and skin; lasers for the medical and… Owned by: Cutera, Inc. Serial Number: 87107838 PICO GENESIS Laser and light based medical devices for the medical and aesthetic treatment of face and skin Owned by: Cutera, Inc. Serial Number: 87185175
Lawsuits:	DeCarlo v. Cutera Inc Plaintiff: Linda DeCarlo Defendant: Cutera Inc Case Number: 3:2017cv05997 Filed: December 1, 2017 Court: Washington Western District Court Office: Tacoma Office County: Pierce Presiding Judge: Ronald B. Leighton Nature of Suit: Other Cause of Action: 28:1332 Jury Demanded By: None Bridgeport Pain Control Center, Ltd. Vs. Cutera, Inc., et al, No. 1:2008cv01116 - Document 43 (N.D. Ill. 2009) Candlewood Aesthetics Med Spa and Laser Center v. Cutera, inc. Plaintiff: Candlewood Aesthetics Med Spa and Laser Center Defendant: Cutera, Inc. Case Number: 3:2018cv00386 Filed: March 5, 2018 Court: Connecticut District Court Office: New Haven Office County: Fairfield Presiding Judge: Michael P. Shea Nature of Suit: Other Contract Cause of Action: 28:1332 Jury Demanded By: Plaintiff Cutera Inc v. Palomar Medical Technologies Inc et al Case Number: 4:2005cv02749 Filed: July 5, 2005 Court: California Northern District Court Office: Oakland Office Presiding Judge: Claudia Wilken Nature of Suit: Patent Cause of Action: 28:1338 Patent Infringement Jury Demanded By: None
OFAC Sanctions List Search:	The company is not listed in the OFAC list.
SUMMARY Cutera Inc. was founded and incorporated in 1998. Cutera, Inc., is a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. It employs a staff of 230 Employees and has an annual revenue of USD Mil 118.06. It mainly exports to Mexico, but does not show any import records. It is ACTIVE in CALIFORNIA, USA; with no negative records.
RISK INFORMATION
DEBTS	Controlled
PAYMENTS	Regular
CASH FLOW	Normal
STATUS	ACTIVE
INTERVIEW
NAME	NA
POSITION	NA
COMMENTS	We tried calling several times but always reached their voicemail. We left a message in their voicemail asking for information and asking them to return our call. If they do so, we will let you know.

FOREIGN EXCHANGE RATES

Currency	Unit	Indian Rupees
US Dollar	1	INR 65.78
UK Pound	1	INR 93.42
Euro	1	INR 81.39
USD	1	INR 66.04

Note: Above are approximate rates obtained from sources believed to be correct

INFORMATION DETAILS

Analysis Done by :	NIS
Report Prepared by :	NIT

RATING EXPLANATIONS

Credit Rating	Explanation	Rating Comments
A++	Minimum Risk	Business dealings permissible with minimum risk of default
A+	Low Risk	Business dealings permissible with low risk of default
A	Acceptable Risk	Business dealings permissible with moderate risk of default
B	Medium Risk	Business dealings permissible on a regular monitoring basis
C	Medium High Risk	Business dealings permissible preferably on secured basis
D	High Risk	Business dealing not recommended or on secured terms only
NB	New Business	No recommendation can be done due to business in infancy stage
NT	No Trace	No recommendation can be done as the business is not traceable

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

· Financial condition covering various ratios

· Company background and operations size

· Promoters / Management background

· Payment record

· Litigation against the subject

· Industry scenario / competitor analysis

· Supplier / Customer / Banker review (wherever available)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.